Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retatrutide is a next-generation synthetic peptide acting as a triple receptor agonist, simultaneously targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
Therapeutic Scope and the Translational Mismatch Problem Clinically, GLP-1RAs are established therapies for obesity and type 2 diabetes (T2D), with expanding indications and ongoing investigation across multiple organ systems
Its up to you and your healthcare provider to determine if GLP-1s are right for you
They did everything they said and I am down 8lbs from 12/20 when I took my 1st injection
Each has distinct clinical features but shares overlapping molecular mechanisms driven by chronic hyperglycemia-induced ROS overproduction
Staying hydrated is a critical component of any weight loss program involving GLP-1 medications
